local_hospital

Danderyd Hospital

Address
lock Available on a paid plan

Danderyd Hospital - Women's Health Research Center

Danderyd Hospital is a leading clinical research facility dedicated to advancing treatment options for women's health conditions. The center specializes in conducting rigorous clinical trials that evaluate novel therapeutic interventions for gynecological disorders, with a particular emphasis on endometriosis-related pain management.

  • Endometriosis pain management and innovative pharmacological treatments
  • Evaluation of dose-response relationships in chronic pelvic pain conditions
  • Patient-reported outcome measures using validated pain assessment scales

The hospital's research programs focus on phase II and III clinical trials that assess both efficacy and safety profiles of investigational compounds. Their expertise includes the use of electronic diary systems for real-time pain monitoring and the implementation of Numeric Rating Scales (NRS) to capture patient experiences in endometriosis management, contributing valuable evidence to improve quality of life for women suffering from chronic gynecological conditions.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
1
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 188 other sites in Sweden

description
Trial volume
1
Outperforms 2% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
1sponsors
Outperforms 2% of sites

Therapeutic Area Benchmark — Sweden

Select a therapeutic area to compare against other sites in Sweden.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Sweden

Market Share

Country: Sweden

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Danderyd Hospital

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
For-62191Unknown2024-02-052024-02-05

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.